Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Pabinger

Showing results (131-140 of 211) with videos related to

Pageof 22
Sort By:
Annals of Hematology|August 20, 2002
Massive postoperative intramuscular bleeding in acquired von Willebrand's diseaseM Krebs, B Meyer, P Quehenberger, et al.
Thrombosis and Haemostasis|September 9, 2011
The role of fibrinogen plasma levels, the -455G>A fibrinogen and the factor XIII A subunit (FXIII-A) Val34Leu polymorphism in cancer-associated venous thrombosisV Tiedje, D Dunkler, C Ay, et al.
Journal of Thrombosis and Haemostasis : JTH|March 11, 2004
Impact of environmental and hereditary risk factors on the clinical manifestation of thrombophilia in homozygous carriers of factor V:G1691AS Ehrenforth, L Nemes, C Mannhalter, et al.
Atherosclerosis|December 15, 2005
C-reactive protein 3' UTR +1444C>T polymorphism in patients with spontaneous venous thromboembolismR Vormittag, M Funk, C Mannhalter, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 10, 2013
Pregnancy complications and obstetric care in women with inherited bleeding disordersR A Kadir, J Davies, R Winikoff, et al.
Scandinavian Journal of Haematology|April 1, 1985
Deficiency of fibrinogen and factor VII following treatment of severe aplastic anaemia with anti-thymocyte globulin and high-dose methylprednisoloneM Fischer, K Lechner, W Hinterberger, et al.
Thrombosis and Haemostasis|December 7, 1992
Recurrent, isolated factor X deficiency in myeloma: repeated normalization of factor X levels after cytostatic chemotherapy followed by late treatment failure associated with the development of systemic amyloidosisI Schwarzinger, M Stain-Kos, P Bettelheim, et al.
Blut|November 1, 1984
Efficacy of the M-2 protocol in previously untreated patients with advanced multiple myelomaH Gössinger, P Bettelheim, E Neumann, et al.
Kidney International|December 1, 1990
Effect of conjugated estrogens on platelet function and prostacyclin generation in CRFM Heistinger, F Stockenhuber, B Schneider, et al.
Blood|January 15, 1997
A single genetic origin for a common Caucasian risk factor for venous thrombosisA Zivelin, J H Griffin, X Xu, et al.
Pageof 22

Showing results (131-140 of 211) with videos related to

Sort By:
Pageof 22
Annals of Hematology|August 20, 2002
Massive postoperative intramuscular bleeding in acquired von Willebrand's diseaseM Krebs, B Meyer, P Quehenberger, et al.
Thrombosis and Haemostasis|September 9, 2011
The role of fibrinogen plasma levels, the -455G>A fibrinogen and the factor XIII A subunit (FXIII-A) Val34Leu polymorphism in cancer-associated venous thrombosisV Tiedje, D Dunkler, C Ay, et al.
Journal of Thrombosis and Haemostasis : JTH|March 11, 2004
Impact of environmental and hereditary risk factors on the clinical manifestation of thrombophilia in homozygous carriers of factor V:G1691AS Ehrenforth, L Nemes, C Mannhalter, et al.
Atherosclerosis|December 15, 2005
C-reactive protein 3' UTR +1444C>T polymorphism in patients with spontaneous venous thromboembolismR Vormittag, M Funk, C Mannhalter, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 10, 2013
Pregnancy complications and obstetric care in women with inherited bleeding disordersR A Kadir, J Davies, R Winikoff, et al.
Scandinavian Journal of Haematology|April 1, 1985
Deficiency of fibrinogen and factor VII following treatment of severe aplastic anaemia with anti-thymocyte globulin and high-dose methylprednisoloneM Fischer, K Lechner, W Hinterberger, et al.
Thrombosis and Haemostasis|December 7, 1992
Recurrent, isolated factor X deficiency in myeloma: repeated normalization of factor X levels after cytostatic chemotherapy followed by late treatment failure associated with the development of systemic amyloidosisI Schwarzinger, M Stain-Kos, P Bettelheim, et al.
Blut|November 1, 1984
Efficacy of the M-2 protocol in previously untreated patients with advanced multiple myelomaH Gössinger, P Bettelheim, E Neumann, et al.
Kidney International|December 1, 1990
Effect of conjugated estrogens on platelet function and prostacyclin generation in CRFM Heistinger, F Stockenhuber, B Schneider, et al.
Blood|January 15, 1997
A single genetic origin for a common Caucasian risk factor for venous thrombosisA Zivelin, J H Griffin, X Xu, et al.
Pageof 22